Literature DB >> 21536167

Immunity, aging, and geriatric depression.

Sarah Shizuko Morimoto1, George S Alexopoulos.   

Abstract

Inflammatory processes are likely to play a causal role in geriatric depression. Geriatric depression occurs in the context of illnesses in which inflammatory processes are part of the pathogenesis. Both aging and depression are associated with immune responses, and the connectivity among mood-regulating structures may be modulated by inflammatory responses. Geriatric depression exacerbates the symptoms of comorbid disorders. Geriatric depression often occurs in persons exposed to chronic stress, a state precipitating geriatric depression and triggering proinflammatory responses. The successful treatment of comorbid conditions that increase central nervous system inflammatory responses has general health benefits and should be part of clinical practice.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21536167      PMCID: PMC3099456          DOI: 10.1016/j.psc.2011.02.006

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  91 in total

Review 1.  Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment.

Authors:  Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2003-02       Impact factor: 7.217

2.  Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission.

Authors:  M Kubera; G Kenis; E Bosmans; A Zieba; D Dudek; G Nowak; M Maes
Journal:  Pol J Pharmacol       Date:  2000 May-Jun

3.  Effects of fetal alcohol exposure on fever, sickness behavior, and pituitary-adrenal activation induced by interleukin-1 beta in young adult rats.

Authors:  R Yirmiya; D L Tio; A N Taylor
Journal:  Brain Behav Immun       Date:  1996-09       Impact factor: 7.217

4.  Inflammatory markers in late-life depression: results from a population-based study.

Authors:  M A Bremmer; A T F Beekman; D J H Deeg; B W J H Penninx; M G Dik; C E Hack; W J G Hoogendijk
Journal:  J Affect Disord       Date:  2007-08-22       Impact factor: 4.839

5.  The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.

Authors:  N Müller; M J Schwarz; S Dehning; A Douhe; A Cerovecki; B Goldstein-Müller; I Spellmann; G Hetzel; K Maino; N Kleindienst; H-J Möller; V Arolt; M Riedel
Journal:  Mol Psychiatry       Date:  2006-02-21       Impact factor: 15.992

6.  Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

Authors:  Daniel Lindqvist; Shorena Janelidze; Peter Hagell; Sophie Erhardt; Martin Samuelsson; Lennart Minthon; Oskar Hansson; Maria Björkqvist; Lil Träskman-Bendz; Lena Brundin
Journal:  Biol Psychiatry       Date:  2009-03-06       Impact factor: 13.382

Review 7.  Microglial degeneration in the aging brain--bad news for neurons?

Authors:  Wolfgang J Streit; Kelly R Miller; Kryslaine O Lopes; Emalick Njie
Journal:  Front Biosci       Date:  2008-05-01

8.  Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity.

Authors:  Zhong Xie; Todd E Morgan; Irina Rozovsky; Caleb E Finch
Journal:  Exp Neurol       Date:  2003-07       Impact factor: 5.330

9.  Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study.

Authors:  Yuri Milaneschi; Anna Maria Corsi; Brenda W Penninx; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  Biol Psychiatry       Date:  2008-12-25       Impact factor: 13.382

10.  Interleukin-6 and selected plasma proteins in healthy persons of different ages.

Authors:  K Hager; U Machein; S Krieger; D Platt; G Seefried; J Bauer
Journal:  Neurobiol Aging       Date:  1994 Nov-Dec       Impact factor: 4.673

View more
  6 in total

Review 1.  Neuroplasticity-based computerized cognitive remediation for geriatric depression.

Authors:  Sarah Shizuko Morimoto; Bruce E Wexler; George S Alexopoulos
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-27       Impact factor: 3.485

2.  Low 25-hydroxyvitamin D concentrations predict incident depression in well-functioning older adults: the health, aging, and body composition study.

Authors:  Julie A Williams; Kaycee M Sink; Janet A Tooze; Hal H Atkinson; Jane A Cauley; Kristine Yaffe; Frances A Tylavsky; Susan M Rubin; Eleanor M Simonsick; Stephen B Kritchevsky; Denise K Houston
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-10-18       Impact factor: 6.053

Review 3.  Cognitive deficits in geriatric depression: clinical correlates and implications for current and future treatment.

Authors:  Sarah Shizuko Morimoto; George S Alexopoulos
Journal:  Psychiatr Clin North Am       Date:  2013-10-06

4.  Age-Dependent Neuroimmune Modulation of IGF-1R in the Traumatic Mice.

Authors:  Hui Zhao; Xiaocong Zhao; Xiaoding Cao; Gencheng Wu
Journal:  Immun Ageing       Date:  2012-05-28       Impact factor: 6.400

5.  Systematic metabolic characterization of mental disorders reveals age-related metabolic disturbances as potential risk factors for depression in older adults.

Authors:  Yu Liu; Wanyu Zhao; Ying Lu; Yunli Zhao; Yan Zhang; Miao Dai; Shan Hai; Ning Ge; Shuting Zhang; Mingjin Huang; Xiaohui Liu; Shuangqing Li; Jirong Yue; Peng Lei; Biao Dong; Lunzhi Dai; Birong Dong
Journal:  MedComm (2020)       Date:  2022-09-30

Review 6.  Major Depression: One Brain, One Disease, One Set of Intertwined Processes.

Authors:  Elena V Filatova; Maria I Shadrina; Petr A Slominsky
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.